Status:
UNKNOWN
Metabolic Disorders in Polycystic Ovarian Syndrome
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
17-40 years
Brief Summary
The purpose of this study is to elucidate the significance of adipocytokine in women with PCOS among adiposity, hyperandrogenism and insulin resistance.
Detailed Description
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age with a probable prevalence of 5% to 10%. PCOS is characterized by chronic anovulation, menstrual irregul...
Eligibility Criteria
Inclusion
- 1\. Oligomenorrhea ( less than 6 times spontaneous MC per year) or Amenorrhea. 2. Hyperandrogenism (either clinical or biochemistry. 3. PCO by ultrasound. 4.After menarche, before menopause.
Exclusion
- 1\. hormone therapy in the past 6 months. 2. Pregnancy in the past 6 months 3.Acute illness found in the past 3 months. 4.Systemic disease including autoimmune disease, malignancy, hepatic, renal or CVS disease, and ever received chemotherapy or immunosuppressive agents.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
OBSERVATIONAL
End Date :
August 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00172523
Start Date
October 1 2004
End Date
August 1 2005
Last Update
September 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology, National Taiwan University Hospital
Taipei, Taiwan